{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:14Z","timestamp":1740136334970,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Afyonkarahisar Health Science University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide and caused mortality. Many factors have been reported to affect the prognosis of COVID-19. In this study, we aimed to investigate the effects of drug therapy and vaccination on prognosis in patients hospitalized with a COVID-19 diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this single-center, cross-sectional study, data were retrospectively collected from patients receiving inpatient treatment at a university hospital with a diagnosis of COVID-19 between January 1, 2020, and April 30, 2022. The patients\u2019 demographic and clinical characteristics were recorded. The Chi-square, Cox and logistic regression was performed, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 was considered statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total 1723 patients (50.1% were men, mean age: 60.6\u2009\u00b1\u200916.90) who had not been vaccinated rate was 27.0% (&gt;\u20093 doses: 45.7%). Mortality rate was 17.0%. Increasing age, male, a high Charlson Comorbidity Index (CCI), and no vaccination significantly increased mortality (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The mortality rate was significantly lower in the chloroquine treatment group than in the other treatment groups. Increasing age, male, and a high CCI were determined to be factors that significantly increased the length of hospital stay (LOHS). LOHS found to be significantly lower in the favipiravir or chloroquine groups compared to the remaining treatment groups (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Both mortality and the LOHS significantly differed according to AST, d-dimer, ferritin, and GFR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study primarily investigated the effect of treatment and vaccination on the prognosis of COVID-19. This was determined to be prepared for another potential pandemic that may arise due to COVID-19.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10787-024-01457-4","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T17:01:51Z","timestamp":1710608511000},"page":"1817-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-2416","authenticated-orcid":false,"given":"Seyma","family":"Oncu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,16]]},"reference":[{"issue":"14","key":"1457_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jama.2020.3413","volume":"323","author":"AA Adalja","year":"2020","unstructured":"Adalja AA, Toner E, Inglesby TV (2020) Priorities for the US Health Community responding to COVID-19. JAMA 323(14):1343\u20131344. https:\/\/doi.org\/10.1001\/jama.2020.3413","journal-title":"JAMA"},{"key":"1457_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.02.009","volume":"63","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Jafri L (2021) Evaluation of serum ferritin for prediction of severity and mortality in COVID-19\u2014a cross sectional study. Ann Med Surg (lond) 63:102163. https:\/\/doi.org\/10.1016\/j.amsu.2021.02.009","journal-title":"Ann Med Surg (lond)"},{"issue":"7","key":"1457_CR3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/03007995.2021.1920900","volume":"37","author":"A Alamer","year":"2021","unstructured":"Alamer A, Alrashed AA, Alfaifi M et al (2021) Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis. Curr Med Res Opin 37(7):1085\u20131097. https:\/\/doi.org\/10.1080\/03007995.2021.1920900","journal-title":"Curr Med Res Opin"},{"key":"1457_CR4","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/IJGM.S329881","volume":"14","author":"M Alotaibi","year":"2021","unstructured":"Alotaibi M, Ali A, Bakhshwin D, Alatawi Y, Alotaibi S, Alhifany A, Alharthi B, Alharthi N, Alyazidi A, Alharthi Y, Alrafiah A (2021) Effectiveness and safety of favipiravir compared to hydroxychloroquine for management of Covid-19: a retrospective study. Int J Gen Med 14:5597\u20135606. https:\/\/doi.org\/10.2147\/IJGM.S329881","journal-title":"Int J Gen Med"},{"key":"1457_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/JMDH.S304788","volume":"14","author":"H Alwafi","year":"2021","unstructured":"Alwafi H, Naser AY, Qanash S et al (2021) Predictors of length of hospital stay, mortality, and outcomes among hospitalised COVID-19 patients in Saudi Arabia: a cross-sectional study. J Multidiscip Healthc 14:839\u2013852. https:\/\/doi.org\/10.2147\/JMDH.S304788","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"1457_CR6","doi-asserted-by":"publisher","first-page":"20731","DOI":"10.1038\/s41598-020-77698-4","volume":"10","author":"M Bellan","year":"2020","unstructured":"Bellan M, Patti G, Hayden E et al (2020) Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep 10(1):20731. https:\/\/doi.org\/10.1038\/s41598-020-77698-4","journal-title":"Sci Rep"},{"key":"1457_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa478","volume":"2020","author":"A Bhimraj","year":"2020","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O\u2019Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y (2020) Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2020:ciaa478. https:\/\/doi.org\/10.1093\/cid\/ciaa478","journal-title":"Clin Infect Dis"},{"key":"1457_CR8","doi-asserted-by":"publisher","first-page":"205031212110703","DOI":"10.1177\/20503121211070366","volume":"10","author":"A Birhanu","year":"2022","unstructured":"Birhanu A, Merga BT, Ayana GM, Alemu A, Negash B, Dessie Y (2022) Factors associated with prolonged length of hospital stay among COVID-19 cases admitted to the largest treatment center in Eastern Ethiopia. SAGE Open Med 10:20503121211070370. https:\/\/doi.org\/10.1177\/20503121211070366","journal-title":"SAGE Open Med"},{"issue":"6","key":"1457_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5144\/0256-4947.2021.327","volume":"41","author":"T Birtay","year":"2021","unstructured":"Birtay T, Bahadir S, Kabacaoglu E, Yetiz O, Demirci MF, Genctoy G (2021) Prognosis of patients hospitalized with a diagnosis of COVID-19 pneumonia in a tertiary hospital in Turkey. Ann Saudi Med 41(6):327\u2013335. https:\/\/doi.org\/10.5144\/0256-4947.2021.327","journal-title":"Ann Saudi Med"},{"issue":"3","key":"1457_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/hep.31326","volume":"73","author":"PP Bloom","year":"2021","unstructured":"Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT (2021) Liver biochemistries in hospitalized patients with COVID-19. Hepatology 73(3):890\u2013900. https:\/\/doi.org\/10.1002\/hep.31326","journal-title":"Hepatology"},{"key":"1457_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fmed.2020.00431","volume":"7","author":"U Boregowda","year":"2020","unstructured":"Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H (2020) Serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis. Front Med (lausanne) 7:431. https:\/\/doi.org\/10.3389\/fmed.2020.00431","journal-title":"Front Med (lausanne)"},{"issue":"10","key":"1457_CR12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","volume":"6","author":"Q Cai","year":"2020","unstructured":"Cai Q, Yang M, Liu D et al (2020) Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (beijing) 6(10):1192\u20131198. https:\/\/doi.org\/10.1016\/j.eng.2020.03.007","journal-title":"Engineering (beijing)"},{"key":"1457_CR13","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R (2023). Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"key":"1457_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.138882","volume":"728","author":"I Chakraborty","year":"2020","unstructured":"Chakraborty I, Maity P (2020) COVID-19 outbreak: migration, effects on society, global environment and prevention. Sci Total Environ 728:138882. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.138882","journal-title":"Sci Total Environ"},{"key":"1457_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.20040758","author":"Z Chen","year":"2020","unstructured":"Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, Zhuang R, Hu B, Zhang Z (2020) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. Medrxiv. https:\/\/doi.org\/10.1101\/2020.03.22.20040758","journal-title":"Medrxiv"},{"issue":"1","key":"1457_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/vaccines10010107","volume":"10","author":"S Cocchio","year":"2022","unstructured":"Cocchio S, Zabeo F, Facchin G, Piva N, Furlan P, Nicoletti M, Saia M, Tonon M, Mongillo M, Russo F, Baldo V (2022) The effectiveness of a diverse COVID-19 vaccine portfolio and its impact on the persistence of positivity and length of hospital stays: the Veneto region\u2019s experience. Vaccines (basel) 10(1):107. https:\/\/doi.org\/10.3390\/vaccines10010107","journal-title":"Vaccines (basel)"},{"issue":"3","key":"1457_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","volume":"166","author":"HM Dabbous","year":"2021","unstructured":"Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA (2021) Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol 166(3):949\u2013954","journal-title":"Arch Virol"},{"issue":"3","key":"1457_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248580","volume":"16","author":"FSH de Souza","year":"2021","unstructured":"de Souza FSH, Hojo-Souza NS, Batista BDO, da Silva CM, Guidoni DL (2021) On the analysis of mortality risk factors for hospitalized COVID-19 patients: a data-driven study using the major Brazilian database. PLoS ONE 16(3):e0248580. https:\/\/doi.org\/10.1371\/journal.pone.0248580","journal-title":"PLoS ONE"},{"issue":"7","key":"1457_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.medcle.2020.11.015","volume":"156","author":"F Deng","year":"2021","unstructured":"Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W (2021) Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (engl Ed) 156(7):324\u2013331. https:\/\/doi.org\/10.1016\/j.medcle.2020.11.015","journal-title":"Med Clin (engl Ed)"},{"issue":"4","key":"1457_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"issue":"10","key":"1457_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051506","volume":"11","author":"F Fortunato","year":"2021","unstructured":"Fortunato F, Martinelli D, Lo Caputo S, Santantonio T, Dattoli V, Lopalco PL, Prato R (2021) Sex and gender differences in COVID-19: an Italian local register-based study. BMJ Open 11(10):e051506. https:\/\/doi.org\/10.1136\/bmjopen-2021-051506","journal-title":"BMJ Open"},{"issue":"2","key":"1457_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"YD Gao","year":"2021","unstructured":"Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Br\u00fcggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA (2021) Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 76(2):428\u2013455. https:\/\/doi.org\/10.1111\/all.14657","journal-title":"Allergy"},{"issue":"2","key":"1457_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/03007995.2022.2148460","volume":"39","author":"TE Gedik","year":"2023","unstructured":"Gedik TE, Unal D, Suzan V, Bag Soytas R, Arman P, Bektan Kanat B, Ulugerger Avci G, Suna Erdincler D, Doventas A, Yavuzer H (2023) The impact of COVID-19 pandemic on the geriatric inpatient unit. Curr Med Res Opin 39(2):259\u2013265. https:\/\/doi.org\/10.1080\/03007995.2022.2148460","journal-title":"Curr Med Res Opin"},{"issue":"25","key":"1457_CR24","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382(25):2411\u20132418. https:\/\/doi.org\/10.1056\/NEJMoa2012410","journal-title":"N Engl J Med"},{"key":"1457_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100591","volume":"28","author":"P Guisado-Vasco","year":"2020","unstructured":"Guisado-Vasco P, Valderas-Ortega S, Carral\u00f3n-Gonz\u00e1lez MM et al (2020) Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: a retrospective observational study (COQUIMA cohort). EclinicalMedicine 28:100591. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100591","journal-title":"EclinicalMedicine"},{"issue":"1","key":"1457_CR26","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1038\/s41598-021-86853-4","volume":"11","author":"A Guo","year":"2021","unstructured":"Guo A, Lu J, Tan H, Kuang Z, Luo Y, Yang T, Xu J, Yu J, Wen C, Shen A (2021) Risk factors on admission associated with hospital length of stay in patients with COVID-19: a retrospective cohort study. Sci Rep 11(1):7310. https:\/\/doi.org\/10.1038\/s41598-021-86853-4","journal-title":"Sci Rep"},{"issue":"10","key":"1457_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jamainternmed.2022.4299","volume":"182","author":"FP Havers","year":"2022","unstructured":"Havers FP, Pham H, Taylor CA et al (2022) COVID-19-associated hospitalizations among vaccinated and unvaccinated adults 18 years or older in 13 US states, January 2021 to April 2022. JAMA Intern Med 182(10):1071\u20131081. https:\/\/doi.org\/10.1001\/jamainternmed.2022.4299","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1457_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.arcmed.2020.07.003","volume":"51","author":"DR Hern\u00e1ndez-Galdamez","year":"2020","unstructured":"Hern\u00e1ndez-Galdamez DR, Gonz\u00e1lez-Block M\u00c1, Romo-Due\u00f1as DK, Lima-Morales R, Hern\u00e1ndez-Vicente IA, Lumbreras-Guzm\u00e1n M, M\u00e9ndez-Hern\u00e1ndez P (2020) Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res 51(7):683\u2013689. https:\/\/doi.org\/10.1016\/j.arcmed.2020.07.003","journal-title":"Arch Med Res"},{"issue":"2","key":"1457_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/pathogens10020217","volume":"10","author":"TC Ho","year":"2021","unstructured":"Ho TC, Wang YH, Chen YL, Tsai WC, Lee CH, Chuang KP, Chen YA, Yuan CH, Ho SY, Yang MH, Tyan YC (2021) Chloroquine and hydroxychloroquine: efficacy in the treatment of the COVID-19. Pathogens 10(2):217. https:\/\/doi.org\/10.3390\/pathogens10020217","journal-title":"Pathogens"},{"issue":"2","key":"1457_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12788\/jhm.3552","volume":"16","author":"LI Horwitz","year":"2021","unstructured":"Horwitz LI, Jones SA, Cerfolio RJ, Francois F, Greco J, Rudy B, Petrilli CM (2021) Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med 16(2):90\u201392. https:\/\/doi.org\/10.12788\/jhm.3552","journal-title":"J Hosp Med"},{"issue":"5","key":"1457_CR31","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.26355\/eurrev_202203_28248","volume":"26","author":"YZ Huang","year":"2022","unstructured":"Huang YZ, Kuan CC (2022) Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 26(5):1770\u20131776. https:\/\/doi.org\/10.26355\/eurrev_202203_28248","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1457_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jmcb\/mjaa014","volume":"12","author":"M Huang","year":"2020","unstructured":"Huang M, Tang T, Pang P et al (2020) Treating COVID-19 with chloroquine. J Mol Cell Biol 12(4):322\u2013325. https:\/\/doi.org\/10.1093\/jmcb\/mjaa014","journal-title":"J Mol Cell Biol"},{"key":"1457_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117788","volume":"254","author":"M Kermali","year":"2020","unstructured":"Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A (2020) The role of biomarkers in diagnosis of COVID-19\u2014a systematic review. Life Sci 254:117788. https:\/\/doi.org\/10.1016\/j.lfs.2020.117788","journal-title":"Life Sci"},{"key":"1457_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106433","volume":"183","author":"N Kokturk","year":"2021","unstructured":"Kokturk N, Babayigit C, Kul S et al (2021) The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med 183:106433. https:\/\/doi.org\/10.1016\/j.rmed.2021.106433","journal-title":"Respir Med"},{"issue":"10","key":"1457_CR35","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel FA (2020) Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol 92(10):1733\u20131734. https:\/\/doi.org\/10.1002\/jmv.25819","journal-title":"J Med Virol"},{"issue":"2","key":"1457_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101569","volume":"25","author":"K Lino","year":"2021","unstructured":"Lino K, Guimar\u00e3es GMC, Alves LS, Oliveira AC, Faustino R, Fernandes CS, Tupinamb\u00e1 G, Medeiros T, Silva AAD, Almeida JR (2021) Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality. Braz J Infect Dis 25(2):101569. https:\/\/doi.org\/10.1016\/j.bjid.2021.101569","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"1457_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/00045632211014244","volume":"59","author":"RS Loomba","year":"2022","unstructured":"Loomba RS, Villarreal EG, Farias JS, Aggarwal G, Aggarwal S, Flores S (2022) Serum biomarkers for prediction of mortality in patients with COVID-19. Ann Clin Biochem 59(1):15\u201322. https:\/\/doi.org\/10.1177\/00045632211014244","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"1457_CR38","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1111\/epi.16524","volume":"61","author":"L Lu","year":"2020","unstructured":"Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, Mu J, Guo J, Li W, Wang G, Gao H, Zhang Y, Lin M, Chen L, Shen S, Zhang H, Sander JW, Luo J, Chen S, Zhou D (2020) New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia 61(6):e49\u2013e53. https:\/\/doi.org\/10.1111\/epi.16524","journal-title":"Epilepsia"},{"issue":"10","key":"1457_CR39","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.30800","volume":"4","author":"A Macchia","year":"2021","unstructured":"Macchia A, Ferrante D, Angeleri P, Biscayart C, Mariani J, Esteban S, Tablado MR, de Quir\u00f3s FGB (2021) Evaluation of a COVID-19 vaccine campaign and SARS-CoV-2 infection and mortality among adults aged 60 years and older in a middle-income country. JAMA Netw Open 4(10):e2130800. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.30800","journal-title":"JAMA Netw Open"},{"key":"1457_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.annepidem.2021.02.012","volume":"57","author":"A Macedo","year":"2021","unstructured":"Macedo A, Gon\u00e7alves N, Febra C (2021) COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol 57:14\u201321. https:\/\/doi.org\/10.1016\/j.annepidem.2021.02.012","journal-title":"Ann Epidemiol"},{"issue":"9","key":"1457_CR41","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s12603-020-1477-2","volume":"24","author":"A Medetalibeyoglu","year":"2020","unstructured":"Medetalibeyoglu A, Senkal N, Kose M, Catma Y, Bilge Caparali E, Erelel M, Oral Oncul M, Bahat G, Tukek T (2020) Older adults hospitalized with Covid-19: clinical characteristics and early outcomes from a single center in Istanbul. Turkey J Nutr Health Aging 24(9):928\u2013937. https:\/\/doi.org\/10.1007\/s12603-020-1477-2","journal-title":"Turkey J Nutr Health Aging"},{"key":"1457_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2020.101226","volume":"40","author":"E Mehraeen","year":"2020","unstructured":"Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, Moradmand-Badie B, Seyed Alinaghi SA, Jahanfar S (2020) Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr 40:101226. https:\/\/doi.org\/10.1016\/j.eujim.2020.101226","journal-title":"Eur J Integr"},{"issue":"4","key":"1457_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiph.2022.01.013","volume":"15","author":"AA Mutair","year":"2022","unstructured":"Mutair AA, Shamou J, Alhumaid S, Layqah L, Ahmed GY, Thoyaja K, Mohaini MA, Almahmoud S, Barry M, Khan A, Dhama K, Al-Jamea LH, Woodman A, Rabaan AA (2022) Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia. J Infect Public Health 15(4):389\u2013394. https:\/\/doi.org\/10.1016\/j.jiph.2022.01.013","journal-title":"J Infect Public Health"},{"issue":"7","key":"1457_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254066","volume":"16","author":"NT Nguyen","year":"2021","unstructured":"Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A (2021) Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS ONE 16(7):e0254066. https:\/\/doi.org\/10.1371\/journal.pone.0254066","journal-title":"PLoS ONE"},{"issue":"1","key":"1457_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40001-021-00626-3","volume":"27","author":"Z Niknam","year":"2022","unstructured":"Niknam Z, Jafari A, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M, Rasmi Y (2022) Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res 27(1):6. https:\/\/doi.org\/10.1186\/s40001-021-00626-3","journal-title":"Eur J Med Res"},{"issue":"1","key":"1457_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-020-03006-1","volume":"24","author":"P Quah","year":"2020","unstructured":"Quah P, Li A, Phua J (2020) Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care 24(1):285. https:\/\/doi.org\/10.1186\/s13054-020-03006-1","journal-title":"Crit Care"},{"issue":"6","key":"1457_CR47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/antibiotics11060805","volume":"11","author":"P Rattanaumpawan","year":"2022","unstructured":"Rattanaumpawan P, Jirajariyavej S, Lerdlamyong K, Palavutitotai N, Saiyarin J (2022) Real-world effectiveness and optimal dosage of favipiravir for treatment of COVID-19: results from a multicenter observational study in Thailand. Antibiotics (basel) 11(6):805. https:\/\/doi.org\/10.3390\/antibiotics11060805","journal-title":"Antibiotics (basel)"},{"issue":"1","key":"1457_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12916-020-01726-3","volume":"18","author":"EM Rees","year":"2020","unstructured":"Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CAB, Group CW, Jombart T, Procter SR, Knight GM (2020) COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med 18(1):270. https:\/\/doi.org\/10.1186\/s12916-020-01726-3","journal-title":"BMC Med"},{"issue":"5","key":"1457_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jdmv.2020.05.003","volume":"45","author":"M Sakka","year":"2020","unstructured":"Sakka M, Connors JM, H\u00e9kimian G, Martin-Toutain I, Crichi B, Colmegna I, Bonnefont-Rousselot D, Farge D, Frere C (2020) Association between d-dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. J Med Vasc 45(5):268\u2013274. https:\/\/doi.org\/10.1016\/j.jdmv.2020.05.003","journal-title":"J Med Vasc"},{"issue":"21","key":"1457_CR50","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1001\/jama.2020.22240","volume":"324","author":"WH Self","year":"2020","unstructured":"Self WH, Semler MW, Leither LM et al (2020) Effect of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 324(21):2165\u20132176. https:\/\/doi.org\/10.1001\/jama.2020.22240","journal-title":"JAMA"},{"issue":"6","key":"1457_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/CRD.0000000000000330","volume":"28","author":"S Shah","year":"2020","unstructured":"Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J (2020) Elevated d-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis. Cardiol Rev 28(6):295\u2013302. https:\/\/doi.org\/10.1097\/CRD.0000000000000330","journal-title":"Cardiol Rev"},{"key":"1457_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","volume":"76","author":"C Sohrabi","year":"2020","unstructured":"Sohrabi C, Alsafi Z, O\u2019Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg 76:71\u201376. https:\/\/doi.org\/10.1016\/j.ijsu.2020.02.034","journal-title":"Int J Surg"},{"key":"1457_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107522","volume":"95","author":"M Solaymani-Dodaran","year":"2021","unstructured":"Solaymani-Dodaran M, Ghanei M, Bagheri M et al (2021) Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol 95:107522. https:\/\/doi.org\/10.1016\/j.intimp.2021.107522","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1457_CR54","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12879-022-07657-z","volume":"22","author":"M Stepanova","year":"2022","unstructured":"Stepanova M, Lam B, Younossi E et al (2022) The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis 22(1):702. https:\/\/doi.org\/10.1186\/s12879-022-07657-z","journal-title":"BMC Infect Dis"},{"key":"1457_CR55","doi-asserted-by":"publisher","first-page":"9240941","DOI":"10.1155\/2022\/9240941","volume":"2022","author":"A Tawfik","year":"2022","unstructured":"Tawfik A, Alzahrani A, Alharbi S, Almitairi J, Alzahrani A, Alshehri MA, Aldughaim MS, Alothaid H (2022) Effectiveness of early favipiravir therapy in hospitalised COVID-19 patients. Adv Virol 2022:9240941. https:\/\/doi.org\/10.1155\/2022\/9240941","journal-title":"Adv Virol"},{"issue":"10","key":"1457_CR56","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/jmv.26050","volume":"92","author":"W Tian","year":"2020","unstructured":"Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R (2020) Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol 92(10):1875\u20131883. https:\/\/doi.org\/10.1002\/jmv.26050","journal-title":"J Med Virol"},{"issue":"3","key":"1457_CR57","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/jmv.26543","volume":"93","author":"S Tural Onur","year":"2021","unstructured":"Tural Onur S, Alt\u0131n S, Sokucu SN, Fikri BI, Barca T, Bolat E, Toptas M (2021) Could ferritin level be an indicator of COVID-19 disease mortality? J Med Virol 93(3):1672\u20131677. https:\/\/doi.org\/10.1002\/jmv.26543","journal-title":"J Med Virol"},{"key":"1457_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","volume":"103","author":"ZF Udwadia","year":"2021","unstructured":"Udwadia ZF, Singh P, Barkate H, Patil S, Rangwala S, Pendse A, Kadam J, Wu W, Caracta CF, Tandon M (2021) Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis 103:62\u201371. https:\/\/doi.org\/10.1016\/j.ijid.2020.11.142","journal-title":"Int J Infect Dis"},{"key":"1457_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668074","volume":"12","author":"M Valverde-Monge","year":"2021","unstructured":"Valverde-Monge M, Ca\u00f1as JA, Barroso B, Betancor D, Ortega-Martin L, G\u00f3mez-L\u00f3pez A, Rodr\u00edguez-Nieto MJ, Mah\u00edllo-Fern\u00e1ndez I, Sastre J, Del Pozo V (2021) Eosinophils and chronic respiratory diseases in hospitalized COVID-19 patients. Front Immunol 12:668074. https:\/\/doi.org\/10.3389\/fimmu.2021.668074","journal-title":"Front Immunol"},{"key":"1457_CR60","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajem.2020.05.063","volume":"40","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shi L, Wang Y, Yang H (2021) An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients. Am J Emerg Med 40:208\u2013209. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.063","journal-title":"Am J Emerg Med"},{"issue":"1","key":"1457_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261216","volume":"17","author":"Z Wang","year":"2022","unstructured":"Wang Z, Liu Y, Wei L, Ji JS, Liu Y, Liu R, Zha Y, Chang X, Zhang L, Liu Q, Zhang Y, Zeng J, Dong T, Xu X, Zhou L, He J, Deng Y, Zhong B, Wu X (2022) What are the risk factors of hospital length of stay in the novel coronavirus pneumonia (COVID-19) patients? A survival analysis in southwest China. PLoS ONE 17(1):e0261216. https:\/\/doi.org\/10.1371\/journal.pone.0261216","journal-title":"PLoS ONE"},{"issue":"6","key":"1457_CR62","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cmi.2022.01.033","volume":"28","author":"R Whittaker","year":"2022","unstructured":"Whittaker R, Br\u00e5then Kristofferson A, Valcarcel Salamanca B, Sepp\u00e4l\u00e4 E, Golestani K, Kv\u00e5le R, Watle SV, Buanes EA (2022) Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients. Clin Microbiol Infect 28(6):871\u2013878. https:\/\/doi.org\/10.1016\/j.cmi.2022.01.033","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1457_CR63","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"1457_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40560-020-00466-z","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B (2020) D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care 8:49. https:\/\/doi.org\/10.1186\/s40560-020-00466-z","journal-title":"J Intensive Care"},{"key":"1457_CR65","doi-asserted-by":"publisher","first-page":"1125246","DOI":"10.3389\/fimmu.2023.1125246","volume":"14","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jiao B, Qu L, Yang D, Liu R (2023) The development of COVID-19 treatment. Front Immunol 14:1125246. https:\/\/doi.org\/10.3389\/fimmu.2023.1125246","journal-title":"Front Immunol"},{"issue":"4","key":"1457_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.33399\/biibfad.789117","volume":"2","author":"F Zeren","year":"2020","unstructured":"Zeren F, Yilanci V (2020) Analysing spatial patterns of the Covid-19 outbreak in Turkey. Bing\u00f6l \u00dcniv \u0130ktis \u0130dari Bilim Fak Derg 4(2):27\u201340. https:\/\/doi.org\/10.33399\/biibfad.789117","journal-title":"Bing\u00f6l \u00dcniversitesi \u0130ktisadi Ve \u0130dari Bilimler Fak\u00fcltesi Dergisi"},{"issue":"6","key":"1457_CR67","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","volume":"18","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z (2020) D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 18(6):1324\u20131329. https:\/\/doi.org\/10.1111\/jth.14859","journal-title":"J Thromb Haemost"},{"key":"1457_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.757459","volume":"8","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wu Y, He Y, Liu X, Liu M, Tang Y, Li X, Yang G, Liang G, Xu S, Wang M, Wang W (2022) Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study. Front Med (lausanne) 8:757459. https:\/\/doi.org\/10.3389\/fmed.2021.757459","journal-title":"Front Med (lausanne)"},{"issue":"10229","key":"1457_CR69","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01457-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T02:06:25Z","timestamp":1717034785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01457-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,16]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01457-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2024,3,16]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Afyonkarahisar University of Health Sciences (AFSU) Non-Interventional Research Ethics Committee (number: 07.01.2022\/52). Ministry of Health (Turkey) approval number: 2021-12-22T20_29_06.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}